Your browser doesn't support javascript.
loading
Prediction of lung papillary adenocarcinoma-specific survival using ensemble machine learning models.
Xia, Kaide; Chen, Dinghua; Jin, Shuai; Yi, Xinglin; Luo, Li.
Afiliação
  • Xia K; Guiyang Maternal and Child Health Care Hospital, Guiyang Children's Hospital, Guiyang, China.
  • Chen D; Department of General Surgery, The Forth People's Hospital of Guiyang, Guiyang, China.
  • Jin S; School of Big Health, Guizhou Medical University, Guiyang, China.
  • Yi X; Department of Respiratory Medicine, Third Military Medical University, Chongqing, China.
  • Luo L; Department of Clinical Laboratory, The Second People's Hospital of Guiyang, Guiyang, China. xllxmm21@163.com.
Sci Rep ; 13(1): 14827, 2023 09 08.
Article em En | MEDLINE | ID: mdl-37684259
ABSTRACT
Accurate prognostic prediction is crucial for treatment decision-making in lung papillary adenocarcinoma (LPADC). The aim of this study was to predict cancer-specific survival in LPADC using ensemble machine learning and classical Cox regression models. Moreover, models were evaluated to provide recommendations based on quantitative data for personalized treatment of LPADC. Data of patients diagnosed with LPADC (2004-2018) were extracted from the Surveillance, Epidemiology, and End Results database. The set of samples was randomly divided into the training and validation sets at a ratio of 73. Three ensemble models were selected, namely gradient boosting survival (GBS), random survival forest (RSF), and extra survival trees (EST). In addition, Cox proportional hazards (CoxPH) regression was used to construct the prognostic models. The Harrell's concordance index (C-index), integrated Brier score (IBS), and area under the time-dependent receiver operating characteristic curve (time-dependent AUC) were used to evaluate the performance of the predictive models. A user-friendly web access panel was provided to easily evaluate the model for the prediction of survival and treatment recommendations. A total of 3615 patients were randomly divided into the training and validation cohorts (n = 2530 and 1085, respectively). The extra survival trees, RSF, GBS, and CoxPH models showed good discriminative ability and calibration in both the training and validation cohorts (mean of time-dependent AUC > 0.84 and > 0.82; C-index > 0.79 and > 0.77; IBS < 0.16 and < 0.17, respectively). The RSF and GBS models were more consistent than the CoxPH model in predicting long-term survival. We implemented the developed models as web applications for deployment into clinical practice (accessible through https//shinyshine-820-lpaprediction-model-z3ubbu.streamlit.app/ ). All four prognostic models showed good discriminative ability and calibration. The RSF and GBS models exhibited the highest effectiveness among all models in predicting the long-term cancer-specific survival of patients with LPADC. This approach may facilitate the development of personalized treatment plans and prediction of prognosis for LPADC.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma Papilar / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma Papilar / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Ano de publicação: 2023 Tipo de documento: Article